Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain

Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain

**Purpose:** To perform a cost-effectiveness analysis of radium-223 plus Best Supportive Care (BSC) compared to BSC in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and without previous docetaxel treatment in Spain. **Design and methods:** A Markov model was...

Full description

Saved in:
Bibliographic Details
Main Authors: Eva Tirado Mercier, Daniel Callejo Velasco, Marta Rubio Cabezas, Cristina Moretones Agut, Meritxell Granell Villalón
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2018-01-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9777
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items